I D
× COMMENTARYCOVER STORYIN THE NEWSNEWSFRONTSCHEMENTATOR + Show More
Chemical Engineering MagazineChementator Briefs
Depolymerization Last month, DuPont Teijin Films Ltd. (DTF; Contern, Luxembourg;…
BUSINESS NEWSTECHNICAL & PRACTICALFEATURE REPORTFACTS AT YOUR FINGERTIPSTECHNOLOGY PROFILEENVIRONMENTAL MANAGEREQUIPMENT & SERVICESFOCUSNEW PRODUCTS + Show More SHOW PREVIEWS

Comment

Fluor and Bayer break ground as construction starts for new cell culture technology center in California

By Gerald Ondrey |

Fluor Corp. (Irving, Tex.; www.fluor.com) announced that a groundbreaking event was held today for Bayer AG’s (Leverkusen, Germany; www.bayer.com) first-of-a-kind cell culture technology center in Berkeley, California. Fluor is providing a single point of responsibility for engineering, procurement, construction management and commissioning, qualification and validation of the facility that will produce oncology and other therapeutics.

“We look forward to working with Fluor on this exciting project, and benefiting from the company’s expertise in engineering, procurement, construction management and validation — all of which will allow us to have flexible and scalable facilities for the future and enable us to bring new medicines to patients faster,” says Judy Chou, senior vice president and global head of Bayer Biotech.

“We are delighted that Fluor’s innovative plant layout and modularized construction solution will allow Bayer’s strategically important manufacturing facility to be designed and built with capital efficiency and a focus on optimizing the project’s schedule,” says Juan G. Hernandez, president of Fluor’s Life Sciences and Advanced Manufacturing business line. “The facility’s user-friendly, reconfigurable design will facilitate increased speed to market for new life-saving treatments.”

The state-of-the-art, single-use technology (SUT) biopharmaceutical manufacturing facility will be constructed at Bayer’s Berkeley site using land from a demolished office building. In 2018, Fluor engaged in the conceptual study and front-end engineering design for the project which is due for completion in early 2021.

Bayer selected GE Healthcare to provide its FlexFactory SUT platform which will be incorporated into the project through a collaborative subcontract to Fluor. GE Healthcare is supplying all major unit operations, systems and ancillary equipment and components.

Fluor’s scope also includes process integration for the entire facility and all associated utilities. Fluor’s San Francisco office will lead the project with support from the company’s offices in Greenville, South Carolina and Gliwice, Poland.

Related Content
Trey Walters named ASME Fellow
Trey Walters, P.E., President and Founder of Applied Flow Technology (AFT; Colorado Springs, Colo.; www.aft.com), has been named a Fellow…

Chemical Engineering publishes FREE eletters that bring our original content to our readers in an easily accessible email format about once a week.
Subscribe Now
Reduce the Risk of Corrosion in Fertilizer Production
3 Reasons to Automate Sensor Cleaning
Protect Your Turbines from Silica with a Low Maintenance Analyzer
Your Off-line pH Measurements Might Be Misleading and Costing You a Lot of Money
Reduce Explosion Risk in 2 Seconds with In Situ Oxygen Analysis

View More

Live chat by BoldChat